Showing results (391-400 of 414) with videos related to
Sort By:
Pageof 42
Biorxiv : the Preprint Server for Biology|January 23, 2024
Estrogen receptor-related receptor (Esrra) induces ribosomal protein Rplp1-mediated adaptive hepatic translation during prolonged starvationMadhulika Tripathi, Karine Gauthier, Reddemma Sandireddy, et al.Circulation Research|December 21, 2018
GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature DeathShavonn C Harper, Jaslyn Johnson, Giulia Borghetti, et al.Biorxiv : the Preprint Server for Biology|July 3, 2023
Faulty Metabolism: A Potential Instigator of an Aggressive Phenotype in Cdk5-dependent Medullary Thyroid CarcinomaPriyanka Gupta, Brendon Herring, Nilesh Kumar, et al.Circulation Research|September 19, 2015
GDF11 does not rescue aging-related pathological hypertrophyShavonn C Smith, Xiaoxiao Zhang, Xiaoying Zhang, et al.Journal of Medical Virology|July 31, 2021
Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assaysKetki Deshpande, Ullas Pt, Ojas Kaduskar, et al.The Indian Journal of Medical Research|August 14, 2012
Aflatoxin contamination in stored rice variety PAU 201 collected from Punjab, IndiaVasanthi Siruguri, P Uday Kumar, P Raghu, et al.BJU International|December 2, 2025
Urologic chronic pelvic pain syndrome 3-year symptom trajectories: the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Symptom Patterns StudyCatherine S Bradley, Mengying You, Wensheng Guo, et al.Autophagy|February 12, 2025
ESRRA (estrogen related receptor, alpha) induces ribosomal protein RPLP1-mediated adaptive hepatic translation during prolonged starvationMadhulika Tripathi, Karine Gauthier, Reddemma Sandireddy, et al.The Journal of Urology|February 27, 2023
Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network StudyAlisa J Stephens-Shields, H Henry Lai, J Richard Landis, et al.Journal for Immunotherapy of Cancer|July 3, 2026
Emergence of a mixed CAF population by FAP-CD3 T-cell engager limits therapeutic efficacyRobert J Norgard, Joshua R Tagore, Pratha Budhani, et al.Pageof 42